Did I forget to mention that ROSG is a bargain at twice the price? Don't let a 10% gain scare you; there's much more to come.
Sentiment: Strong Buy
You can see that shorts control the price. Today, as on many days, price goes down and then at about 3 p.m., recovers as shorts close their positions. We need some seriously positive news to break this cycle. An upgrade isn't going to cut it.
I may be overlooking a couple companies, but it seems that the entire met and thermal coal industry is crumbling. They all have massive debt and there is nothing on the horizon that indicates a turn around. Bankruptcies among the weakest is the only thing that might prevent the entire industry from imploding.
Sector perform, i.e. don't buy the stock, buy the index. This implies that management's efforts and the resulting success or failure of their drug pipeline will be immaterial. The sector will move SRPT higher or lower? Why does anyone listen to these people? Who pays for this sort of stupid advice?
Put your money where mouth is and buy some of those 6 calls expiring today. Certainly investing 5 cents to make a dollar is an acceptable 6 hour return.
Unfortunately they've gone to the well too many times and each time at a lower price. Will new investors actually be willing to supply funds when ROSG products have yet to generate meaningful revenue? Most biotechs see approved products as the target that will provide great returns to early investors. ROSG has had its tests on the market for years now and still can't get any traction.
Obviously to fund pipeline until products hit the market in 5 years. Better to issue the secondary before you really need the money.
In the last month ROSG has issued several PRs that indicate good things from revenue standpoint are just around the corner. The question I have is whether there's enough cash to get us to the corner. It would seem that others feel the same way, with share lingering around 3. Implication is that another secondary will come out and until the price and dilution becomes public, caution is the key.
I'm just speculating. Until there is significant cash flow, even if not enough to continue funding of operations, share price will have a tough time getting back to the massive secondary we had at 5.
Not sure of why your response got a thumbs down. As far as I'm concerned, anyone who supplies hard information gets a thumbs up. Those who write nothing more than "buy, buy, buy" or "sell, sell, sell" get a thumbs down. They add zero value.
How are they going to collect the methane produced by cows?
Here's just the first paragraph:
"SAN FRANCISCO--(BUSINESS WIRE)-- Solazyme, Inc.(SZYM) , a renewable oil and ingredients company, is pleased to announce that the US Food and Drug Administration (FDA) has issued a favorable response to Solazyme’s notification concluding that Whole Algal Protein is Generally Recognized as Safe (GRAS) as an ingredient in food and beverage products. This No Questions letter will further pave the way for mainstream adoption of this new source of vegan protein enabling the creation of new products that meet consumer demand for healthy, sustainable ingredients."
Nice to see a couple of days of gains holding. Let's hope that was the last time we see $3.00. I think the letter to shareholders had something to do with the positive market for ROSG shares.
You'd think that coal stocks would hold up reasonably well, and yet BTU is down nearly as much as FCX. Meanwhile, FB is virtually flat. I guess if it gets much colder, we'll feel lots better by posting a photo on FB showing us in our parkas.
The TSLA, AAPL, NFLX investors bemoan a share price drop of 2 - 6%. In the meantime, FCX is down better than twice that... again... and yet that is "just the way the market works." If all of the commodities continue to tumble down, there aren't going to be enough folks making money to buy the Tesla or Apple products.